George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
My shares have been transferred today to IPO, trust they have better luck there. Arrivederci IVO
I too am puzzled at the early transfer of shares to Escrow when the CMA are not making a decision on a phase 2 investigation till Oct 24th.
you missed my point. the passive/index side of blackrock will, of course, own IPO. but then it will also own all index constituents on behalf of the ultimate owners of those products. the active fund-management side of blackrock has never, to my knowledge, been a significant/declared fundamental owner of these two stocks. so, i was trying to say that any activity from blackrock was unlikely to be contain much info. but i'm aware that my tone sounds patronising when it's not meant to be, whilst your tone sounds spiky. so let's not pursue this 'conversation' any further. good luck/all best...
It's frozen if you excepted the offer !! What a load of scheisse💩 TD Direct say this as anyone else got this problem??
One I am relaxed two I would check your quote about IPO. I think you will find they are quite big holders their about ten million + and .2 % short also. I agree this is undervalued but not as undervalued as IPO. The value of this will rise after that dump by Blackrock, share was pushed down to cater for the sale. The value of this share is now totally defined by IPOs price until their is a decision by the competition bods.
I think you should relax....Blackrock happen to be one of the largest etf/index players in the market...There's a lot of movement here which is just noise to the likes of us...Given that IP Group is a ftse250 company and IVO shares will convert at the exchange ratio there's a good reason why you will continue to see RNS from Blackrock as the composition of various Blackrock products are changed as the quants rebalance and adjust things. Blackrock have never been fundamental holders of IVO - or of IPO in any real size. I don't see them as being fundamentally relevant. The assets in IVO are what they are - under-valued - as they are at IPO. You should just stay focused on the underlying, in my view.. good luck.
In fact they have dumped 384 thousand +in the last few days?? @a very sad price what an earth do they know ?? Doesn't instill much confidence think I will clean my book 📚 up next week
Blackrock have dumped,all 164 thousand +shares @2.34 lets hope they just got bored,?? On a,serious note does that mean yes or no on takeover?? View anyone 💩
The takeover would have valued this stock @ 266+ this stock is eight %off fair value could be a nice rise tomorrow ???💰🤑
#1 in IVO portfolio companies: NEXEON (from annual report) Net investment carrying value: $41M GBP (33.7% ownership) > $124 M GBP valuation, based on book value recorded by IVO ???
From US Patent Trial and Appeal Board (PTAB): "Nexeon Ltd. (“Petitioner”) filed a Petition (“Pet.”) to institute an inter partes review of claims 1–18 of U.S. Patent No. 7,939,218 B2 (“the ’218 patent,” Ex. 1001). Paper 2. OneD Material, LLC (“Patent Owner”) filed a Preliminary Response (“Prelim. Resp.”). Paper 8. We have jurisdiction under 35 U.S.C. § 314. Upon consideration of the Petition, Preliminary Response, and the evidence of record, we determine that Petitioner has not established a reasonable likelihood of prevailing with respect to the unpatentability of claims 1–18 of the ’218 patent. Accordingly, we deny the Petition and do not institute an inter partes review." just posted by US PTO at https://ptab.uspto.gov/#/login
08/03/2011 | 03:05am EDT Imperial Innovations Group plc (AIM: IVO, 'Innovations', or 'the Group'), the UK's leading technology commercialisation and investment company, has led a £40m investment in Nexeon, a battery materials and licensing company which is developing silicon anodes for the next generation of lithium-ion (Li-ion) batteries. Innovations invested £15.0m with existing Nexeon shareholder Invesco Perpetual also participating. Following this investment, Innovations will hold a 40% (33.5% fully diluted) stake in Nexeon. To date, Nexeon has raised £55m over four funding rounds since formation in 2005. Nexeon’s unique and patented silicon anode technology increases a battery’s energy density, creating longer lasting batteries for the same size of battery or smaller batteries for the same performance. In December 2010, Nexeon announced it had developed Li-ion cells containing its silicon materials that had the world’s highest capacity for their size. Currently, Nexeon has the capability to produce 2,500 kg pa at its Abingdon facility. The new funding will be used to scale-up the production of Nexeon’s silicon anode materials to commercial levels and to provide application development and support to customers. The new manufacturing facility is expected to be on stream in 2013. Nexeon has signed Material Evaluation Agreements with a number of leading battery manufacturers. Li-ion batteries are widely used in consumer electronic applications such as laptops, mobile phones, and tablet computers, and in electric and hybrid vehicles. The global market for Li-ion batteries is currently $10bn, but estimates have suggested that will increase to between $40bn and $60bn over the next decade. Russ Cummings, Innovations’ Chief Investment Officer, led the fund raising and is on Nexeon’s board, whilst Paul Atherton, a non-executive director of Innovations, is Chairman of Nexeon. Susan Searle, Imperial Innovations’ CEO, said: “This investment is a substantial endorsement of Nexeon’s technology and management team. It is in line with our strategy stated at our recent equity raise to accelerate the development of our advanced portfolio companies, as well as to stay invested in some of them for longer. This new funding round will enable Nexeon to scale up the business more quickly and support its manufacturing facility in Abingdon – already one of the most advanced worldwide. Scott Brown, Chief Executive Officer of Nexeon, said: “We are naturally delighted at the support shown by our investors who see the potential of our silicon anode technology and the excellent progress being made by our team. With the strong financial backing of Innovations and Invesco Perpetual, we are well placed and very much on track to meet our customers’ needs and to achieve our commercial ambitions.
The share price of both companies is being eroded by these prolonged negotiations. We have been on a downward spiral since Circassia and the board has done nothing to restore the markets faith, not that IPO is much better but at least the share price heads north now and again. Just get on with it.
not very pleased about this. http://www.lse.co.uk/share-regulatory-news.asp?shareprice=IVO&ArticleCode=34i69pxu&ArticleHeadline=Chairman39s_letter_to_shareholders
If the buyout goes through at 307p there is a upside available in relatively short order override the most recent price. Fact it has not held > 300p is probably telling us something.
- here considering whats going on, may be worth topping up, any thoughts?
https://register.epo.org/application?number=EP15173948&lng=en&tab=doclist Two documents (see link above) from EPO just posted (01.06.2017)
As with with all possibles lets not get too excited it all depends on the price if it becomes a takeover or what ever, it is early days
or whatever, will IPO and IVO merger go thro'? I have a stake in both companies and they are both at bargain prices with huge potential IMO.
https://register.epo.org/application?number=EP12182852&lng=en&tab=doclist See "Annex to the communication - Opposition" , posted on April 4 by European Patent Office in Munich.
From the March 31 2017 IVO Report to Shareholders: Nexeon: With the benefit of the additional £30.0 million equity funding round completed in May 2016, Nexeon is continuing to optimise its silicon materials for the blended carbon/silicon anode applications currently being demanded by the battery industry. Nexeon is increasingly being recognised as the "go to" company for silicon materials in the battery space, which is presenting exciting commercial opportunities. The company recently signed a joint development agreement with an automotive company and is actively sampling kilogram quantities of its products to several tier 1 battery companies From the March 31 2015 IVO Report to Shareholders: Nexeon Limited At 31 January 2015 the Group had a 40.1% interest in Nexeon with a fair value of £34.1 million. Nexeon is a battery materials company that is developing the next generation of lithium ion rechargeable batteries. More specifically, Nexeon is developing a range of silicon anode materials that enable increased capacity without compromising lithium ion battery cycle life, providing the potential for lighter batteries with more power and a longer lifetime between charges. The company has a broad patent portfolio relating to high aspect ratio silicon materials and the use of these materials in lithium ion batteries. Nexeon has raised a total of £55.0 million in investment from a range of investors including Invesco Perpetual and the Group. In April 2014, the company completed the construction and commissioning of its new process development and manufacturing facility plant in Milton Park, Oxford, UK. The plant is capable of producing over 20 tonnes of product a year and has been built to handle a wide range of materials and reagents.
Privately-held companies that are not profitable often need to raise additional equity capital. Your question is how do the owners manage to know whether to invest more and at what price. Until a new financing transaction takes place, the owners typically carry the equity value at the price set in a prior round of financing, and this value is adjusted (up or down) when there is a new financing: an outside investor that makes an independent judgment decides to pay a certain price for a new equity position in the private company. This normally helps the prior owners to adjust the value based on a transaction price set at "arm's length" by a "fresh pair of eyes", presumably looking at higher future value to reward the new investment at that price. This is the "theory" but not always correct in practice. For example, there may be conflict of interest and other reasons for the new investor to decide to pay a certain price for the newly issued equity, which may not reflect the true market value and/or alter judgement. In the case of Nexeon, for example, a new investor (Woodford) purchased some equity last May. However, the CEO of Nexeon is also a Director at Woodford Patient Capital Trust, and there are multiple links (including ownership and financial incentives) between Woodford and Imperial Innovation (now Touchstone Inn.). In short, managing the capital needs of unprofitable profitable companies (like VC funds do) often can be helped by information gained from "external, unrelated party transactions" in a financing round recruiting new investors, who set the price that they are willing to pay. This works well if one can assess whether such transaction is truly "arm's length" so that the price is truly indicative value at that point in time (and the expected future upsides for the risk taken) and, which provides an independent assessment. Of course, new investors can also make mistakes or their judgement may not be independent. It does not work well if there are other factors at play, which may "distort" the price paid for the new equity.
>Still don't like the wide spread Just bought some at 3.09. Dealing online with Barclay Stockbrokers and was first offered 3.19 but declined then instantly tried again and was offered 3.09.
Patent # 8940437 https://ptab.uspto.gov/#/login
New info re Nexeon IP. Enter patent number 8597831 in link: https://ptab.uspto.gov/#/login and download document #46